FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

FDA approved a supplemental application for WELLBUTRIN XL, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• WELLBUTRIN XL (Bupropion hydrochloride)

Snippet

SUPPL AP for WELLBUTRIN XL (BUPROPION HYDROCHLORIDE)